Dr. Reddy’s launches Elobixibat to deal with persistent constipation
Dr. Reddy’s Laboratories has launched Elobixibat, a first-in-class drug to deal with persistent constipation, within the home market. It'll market ...
Saturday, November 23, 2024
Tag: Reddys
Traders Diary: SBI, Dr Reddy’s, Hero MotoCorp are stocks to Buy, Sell or HOLD
In today's edition of Traders Diary, Zee Business research team brings its exclusive research on 20 stocks that investors and traders ...
Dr Reddy’s PAT rises 12% at Rs 1,113 cr in Q2
Dr Reddy's Laboratories Ltd on Friday said its consolidated profit after tax (PAT) for the quarter ended September 30, 2022 ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.